Anchiano Therapeutics Ltd. ANCN
Set alert
No live quote for ANCN yet.
- Open
- 5.10
- Prev close
- 4.47
- Mkt cap
- 34.95M
- Vol
- 25.04M
- Avg vol
- 167.29K
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.60
- High
- 8.20
- Forward P/E
- -7.60
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 61.36
- 200-d avg
- 34.74
- 1y target
- 0.00
Analyst view
Consensus: hold
Hold
Price target (mean) —
Ratings (-1m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 1
- 2 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -0.25 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -2.15 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 17, 2019 | Oppenheimer | Downgrade | Outperform | Perform |
| May 28, 2019 | Baird | Initiated | — | Outperform |
| Mar 10, 2019 | Oppenheimer | Initiated | — | Outperform |